Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease

View source ↗

Summary

This clinical trial update describes investigations into the mechanistic effects of mitapivat in subjects with sickle cell disease, which is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mitapivat (mitapivat)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Anemia, Sickle Cell Thalassemia | Status: ACTIVE_NOT_RECRUITING